VivoSeq
Other

Respiratory Disease

0

Pipeline Programs↗

5

Active Trials↗

1

Companies Involved↗

Respiratory Disease is an early-stage landscape with 0 programs across 1 company. The most active players are Cumberland Pharmaceuticals.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

C

Cumberland Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

19

clinical trials

Completed14 · 74%
Active, not recruiting2 · 11%
Recruiting2 · 11%
Not yet recruiting1 · 5%

Clinical Trials

Trial Activity

19 trials

Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule
Recruiting·—·N/A·NCT06673121·5,000 enrolled
Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases
Recruiting·CCHU de Reims·N/A·NCT02924818·225 enrolled
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
Active, not recruiting·—·Phase 2·NCT05575037·17 enrolled
Effects of Attachment-Based Intervention on Low-Income Latino Children's Emerging Health Outcomes
Active, not recruiting·UUniversity of Maryland, Baltimore·Preclinical·NCT06002685·260 enrolled
Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)
Not yet recruiting·HHenan University of Traditional Chinese Medicine·N/A·NCT06577701·10,000 enrolled
Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
Completed·AAnabio R&D·N/A·NCT06148194·600 enrolled
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
Completed·EElliot Israel, MD·Phase 2·NCT01597375·46 enrolled
The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases
Completed·TTehran University of Medical Sciences·Phase 4·NCT01867281·32 enrolled
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Completed·CCumberland Pharmaceuticals·Phase 2·NCT02216357·19 enrolled
Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at Altitude
Completed·UUniversity of Zurich·Phase 4·NCT03540901·112 enrolled
Altitude Related Illness In Patients With Respiratory Disease
Completed·UUniversity of Zurich·Phase 4·NCT02450968·124 enrolled
Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at Altitude
Completed·UUniversity of Zurich·Phase 4·NCT03177811·127 enrolled
Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at Altitude
Completed·UUniversity of Zurich·Phase 4·NCT03177850·185 enrolled
Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease
Completed·UUniversity of Zurich·Phase 4·NCT03156231·185 enrolled
Dupilumab for Aspirin-exacerbated Respiratory Disease
Completed·RRochester General Hospital·Phase 2·NCT03595488·11 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)